The Omicron variant has moved the COVID-19 pandemic into a new phase and could bring it to an end in Europe, the WHO Europe director said Sunday.
Jan 23, 2022
1
12
Omicron is now the dominant COVID-19 variant circulating in the European Union and European Economic Area (EAA), the bloc's health agency said on Friday.
Jan 21, 2022
0
7
A U.N.-backed organization announced Thursday that it has signed agreements with more than two dozen generic drug makers to produce versions of Merck's COVID-19 pill to supply 105 developing countries.
Jan 20, 2022
0
6
Canada's health authority said Monday it has approved Pfizer's anti-COVID pill, Paxlovid, for adults at high risk of progressing to serious disease.
Jan 17, 2022
0
10
Germany's BioNTech and US pharma giant Pfizer, which together developed a COVID-19 vaccine in record time, said Wednesday they are working on a shingles shot using the same mRNA technology.
Jan 5, 2022
0
6
As the fast-spreading coronavirus variant omicron rages through Western Europe, officials and experts in low-vaccinated Eastern Europe anticipate a post-holiday explosion of COVID-19 cases in much of the region.
Dec 30, 2021
0
20
The omicron variant could be dominant in Germany in one to three weeks, a senior official said Wednesday, while the health minister called for vaccination centers to be kept open over the Christmas holidays to keep the country's ...
Dec 22, 2021
0
0
The European Union is poised to limit the validity of vaccine recognition in its EU COVID certificate to nine months, its executive said on Tuesday, in a bid to encourage boosters.
Dec 21, 2021
0
2
The European Union approved its fifth Covid-19 vaccine Monday, stepping up its battle against the Omicron virus variant as the WHO called for greater efforts to ensure the pandemic ends next year.
Dec 20, 2021
0
8
The European Commission on Monday authorised a vaccine from US company Novavax as its fifth official jab for use across the European Union, hours after the EU medicines watchdog gave approval.
Dec 20, 2021
0
3
